Your browser doesn't support javascript.
loading
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk.
Spina, M; Nagy, Z; Ribera, J M; Federico, M; Aurer, I; Jordan, K; Borsaru, G; Pristupa, A S; Bosi, A; Grosicki, S; Glushko, N L; Ristic, D; Jakucs, J; Montesinos, P; Mayer, J; Rego, E M; Baldini, S; Scartoni, S; Capriati, A; Maggi, C A; Simonelli, C.
Afiliação
  • Spina M; Division of Medical Oncology A, National Cancer Institute, Aviano, Italy mspina@cro.it.
  • Nagy Z; First Department of Medicine, Semmelweis University Medical School, Budapest, Hungary.
  • Ribera JM; ICO-Hospital Germans Trias i Pujol, Jose Carreras Research Institute, UAB, Badalona, Spain.
  • Federico M; Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Aurer I; University Hospital Centre Zagreb and Medical School, Zagreb, Croatia.
  • Jordan K; Department of Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Borsaru G; Department of Hematology, "Coltea" Clinical Hospital, Bucharest, Romania.
  • Pristupa AS; Department of Hematology, Ryazan Regional Clinical Hospital, Ryazan, Russia.
  • Bosi A; Hematology Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.
  • Grosicki S; Department of Cancer Prevention, Faculty of Public Health, Silesian Medical University in Katowice, Katowice, Poland.
  • Glushko NL; Department of Hematology, Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine.
  • Ristic D; Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
  • Jakucs J; First Department of Internal Medicine Endocrinology and Hematology, Pandy Kalman Megyei Korhaz, Gyula, Hungary.
  • Montesinos P; Department of Hematology, Hospital Universitario La Fe, Valencia, Spain.
  • Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Rego EM; Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto-USP, Ribeirão Preto, Brazil.
  • Baldini S; Department of Clinical Research, Menarini Ricerche, Firenze, Italy.
  • Scartoni S; Department of Clinical Research, Menarini Ricerche, Firenze, Italy.
  • Capriati A; Department of Clinical Research, Menarini Ricerche, Firenze, Italy.
  • Maggi CA; Department of Clinical Research, Menarini Ricerche, Firenze, Italy.
  • Simonelli C; Department of Clinical Research, Menarini Ricerche, Firenze, Italy.
Ann Oncol ; 26(10): 2155-61, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26216382
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Lise Tumoral / Alopurinol / Supressores da Gota / Neoplasias Hematológicas / Febuxostat Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Lise Tumoral / Alopurinol / Supressores da Gota / Neoplasias Hematológicas / Febuxostat Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália